Stay updated on Faricimab in Neovascular AMD Clinical Trial

Sign up to get notified when there's something new on the Faricimab in Neovascular AMD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Faricimab in Neovascular AMD Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Publications section now clarifies that some results publications are provided voluntarily by the data submitter and that others are auto-filled from PubMed. The revision version was updated from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T21:48:45.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    - The government's funding status notice has been removed from the page. The TENAYA trial details remain unaffected and continue to be presented.
    Difference
    0.1%
    Check dated 2025-11-17T19:59:05.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Administrative updates to the study page, including the last update posted date and minor text edits in the Study Overview and Study Record. These changes do not affect the study's design, eligibility criteria, outcomes, or results.
    Difference
    0.2%
    Check dated 2025-11-03T13:53:44.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Major update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.
    Difference
    0.9%
    Check dated 2025-10-06T04:27:53.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Upgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.
    Difference
    0.0%
    Check dated 2025-09-29T00:59:14.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The update primarily localizes the location label to 'México' (instead of 'Mexico') while preserving the rest of the address; the page revision is bumped to v3.0.2. A non-critical navigation element 'Back to Top' was removed.
    Difference
    0.1%
    Check dated 2025-09-14T18:44:47.000Z thumbnail image

Stay in the know with updates to Faricimab in Neovascular AMD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Faricimab in Neovascular AMD Clinical Trial page.